Clinical Trial

Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease

Name: Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease — clinical trial record (NCT07451613)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: REGEN4HD

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The purpose of this research study is to determine whether an implantation of hNSC-01 is a safe and tolerable study intervention for Huntington's disease. This study is the first time that hNSC-01 is being tested in people.

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-14

Trial Details

NCT Number	NCT07451613
Lead Sponsor	Leslie Thompson Collaborators: California Institute for Regenerative Medicine (CIRM), University of California, Irvine
Conditions	Huntington Disease
Enrollment	21 participants
Start Date	2026-04-06
Primary Completion	2028-06 (estimated)
Study Completion	2031-01 (estimated)
Updated on ClinicalTrials.gov	2026-04-13